Continuation of prescribed compared with over-the-counter oral contraceptives

Obstetrics and Gynecology

Volumn 117, Issue 3, 2011, Pages 551-557

  Potter, Joseph E ^a   McKinnon, Sarah ^a   Hopkins, Kristine ^a   Amastae, Jon ^a   Shedlin, Michele G ^a   Powers, Daniel A ^a   Grossman, Daniel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; ORAL CONTRACEPTIVE AGENT; PRESCRIPTION DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEXICO; ORAL CONTRACEPTION; OUTPATIENT DEPARTMENT; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; CONTRACEPTIVES, ORAL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEXICO; NONPRESCRIPTION DRUGS; PATIENT ACCEPTANCE OF HEALTH CARE; PROPORTIONAL HAZARDS MODELS; TEXAS; YOUNG ADULT;

EID: 79952031311     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31820afc46     Document Type: Article

References (28)

1. Vaughan B, Trussell J, Kost K, Singh S, Jones R. Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth. Contraception 2008;78:271-83.
2. Potter L. Oral contraceptive compliance and its role in the effectiveness of the method. In: Cramer J, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York (NY): Raven Press; 1991. p. 195-205.
3. Rosenberg MJ, Burnhill MS, Waugh MS, Grimes DA, Hillard PJ. Compliance and oral contraceptives: a review. Contraception 1995;52:137-41.
4. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179:577-82. (Pubitemid 28447229)
5. Frost JJ, Singh S, Finer LB. US women's one-year contraceptive use patterns, 2004. Perspect Sex Reprod Health 2007;39:48-55.
6. Foster DG, Parvataneni R, de Bocanegra HT, Lewis C, Bradsberry M, Darney P. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol 2006;10:1107-14. (Pubitemid 44665404)
7. O'Connell K, Roca C, Westhoff CL. The impact of pack supply on oral contraceptive continuation: a randomized controlled trial. Contraception 2010;82:185-6.
8. Trussell J, Stewart F, Potts M, Guest F, Ellertson C. Should oral contraceptives be available without prescription? Am J Public Health 1993;83:1094-9.
9. Landau SC, Tapias MP, McGhee BT. Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006;74:463-70. (Pubitemid 46037536)
10. Grossman D, Fernández L, Hopkins K, Amastae J, Potter JE. Perceptions of the safety of oral contraceptives among a predominately Latina population in Texas. Contraception 2010;81:254-60.
11. Potter JE, White K, Hopkins K, Amastae J, Grossman D. Clinic versus over-the-counter access to oral contraception: choices women make in El Paso, Texas. Am J Public Health 2010;100:1130-6.
12. Bastida E, Brown HS, Pagan JA. Persistent disparities in the use of health care along the US-Mexico border: an ecological perspective. Am J Public Health 2008;98:1987-95.
13. Amastae J, Fernandez L. Transborder use of medical services among Mexican American students in a U.S. border university. J Borderland Studies 2006;21:77-87.
14. Fernandez L, Howard C, Amastae J. Education, race/ethnicity and out-migration from a border city. Pop Res Policy Rev 2007;26:103-24. (Pubitemid 46554189)
15. Potter JE, Moore A, Byrd T. Cross-border procurement of contraception: estimates from a postpartum survey in El Paso, Texas. Contraception 2003;68:281-7. (Pubitemid 37311368)
16. Westhoff C, Heartwell S, Edwards S, Zieman M, Cushman L, Robilotto C, et al. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecol 2007;109:1270-6. (Pubitemid 46869864)
17. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias - Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278-85. (Pubitemid 46143305)
18. Efron B. The efficiency of Cox's likelihood for censored data. J Am Stat Assoc 1977;72:557-65.
19. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239-41.
20. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York (NY): Springer; 2000.
21. StataCorp. Stata Statistical Software Release 10. College Station, TX: StataCorp LP; 2007.
22. Stuart GS, Grimes DA. Social desirability bias in family planning studies: a neglected problem. Contraception 2009;80:108-12.
23. Frost JJ, Darroch JE. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspect Sex Reprod Health 2008;40:94-104.
24. Frost JJ, Singh S, Finer LB. Factors associated with contraceptive use and nonuse, United States, 2004. Perspect Sex Reprod-Health 2007;39:90-9.
25. Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64-72, 93.
26. Westhoff CL, Heartwell S, Edwards S, Zieman M, Stuart G, Cwiak C, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007;196:6.
27. Crowley JS, Ashner D, Elam L. State Medicaid: outpatient prescription drug policies: findings from a national survey, 2005 update. Washington (DC): The Kaiser Family Foundation; 2005.
28. Grossman D, White K, Hopkins K, Amastae J, Shedlin M, Potter JE. Contraindications to Combined Oral Contraceptives Among Over-the-Counter Compared With Prescription Users. Obstet Gynecol 2011;117:558-65.